RUNX2 and cancer: Nuclear YAP1 can bind ErbB4, TEAD and RUNX2 [50–56] inducing cell proliferation, oncogeneic transformation, and the epithelial-tomesenchymal transition (EMT) et al, which leading to poor cancer prognosis.